Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNG462 in MTAP-deleted Advanced or Metastatic Solid Tumors
NCT05732831Phase 2Recruiting
- Sponsor
- Tango Therapeutics
- Start
- May 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of vopimetostat in solid tumor, sponsored by Tango Therapeutics. Started May 2023; status: recruiting.
02
Drugs
vopimetostat
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05732831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05732831.